Description
The authors suggest that adrenergic receptors on cell types other than microglia (such as astrocytes) may mediate disease-modifying effects, but this remains unproven. Identifying these cellular targets is essential for therapeutic development.
Gap type: open_question Source paper: Impact of noradrenergic inhibition on neuroinflammation and pathophysiology in mouse models of Alzheimer’s disease. (2024, Journal of neuroinflammation, PMID:39696597)